Capula Management’s CareDx CDNA Stock Holding History

Capula Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,427	Closed	-$222K	–	873
2021 Q2	$222K	Buy	+2,427	New	+$193K	﹤0.01%	670

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Capula Management's CDNA Position: Q3 2021 in Review

Capula Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 2,427 shares — an estimated $222K sold.

Capula Management first reported a position in CDNA in Q2 2021 and held it in 1 quarter. The position peaked at $222K in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

Capula Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
Capula Management sold 2,427 CareDx shares in Q3 2021, an estimated $222K.
Capula Management first reported a position in CareDx in Q2 2021 and held it in 1 quarter.
Capula Management's CareDx position peaked at $222K in Q2 2021.
260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Capula Management's 13F filing for Q3 2021, filed 15 Nov 2021.